Delcath Systems Inc is a medical technology company focused on the development and commercialization of innovative therapeutic systems for the treatment of cancer
The company's primary product is a specialized delivery system designed to administer high doses of chemotherapy directly to tumors while reducing systemic exposure and associated side effects. Through its proprietary techniques, Delcath aims to improve treatment outcomes for patients suffering from various types of cancer, particularly liver cancers, by enhancing the efficacy and safety of cancer therapies. The company is dedicated to advancing its technologies and expanding its clinical applications to better serve oncologists and patients in the fight against cancer.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
The Dow Jones index closed higher by over 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
The Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
